Skip to main content

Articles

Page 2 of 59

  1. Sciadonic acid (SA) is an anti-inflammatory fatty acid displacing arachidonic acid (ARA) from specific phospholipid pools, thus modulating downstream pro-inflammatory lipid mediators. Its novel anti-inflammato...

    Authors: Alvin Berger
    Citation: Lipids in Health and Disease 2022 21:40
  2. Low-density lipoprotein cholesterol (LDL-C) is an important cardiovascular disease marker that is used to estimate the risk of acute coronary syndrome in patients. The Sampson equation is an accurate LDL-C equ...

    Authors: Jiayu Li, Yanguo Xin, Jingye Li, Meng Meng, Li Zhou, Hui Qiu, Hui Chen and Hongwei Li
    Citation: Lipids in Health and Disease 2022 21:39
  3. It is unclear why primary nephrotic syndrome (PNS) patients often have dyslipidemia. Recent studies have shown that angiopoietin-like protein 3 (ANGPTL3) is an important regulator of lipid metabolism. In this ...

    Authors: Fu Zhong, Shurao Liu, Yue Li, Guanyu Li, Ming Liu, Jingzhi Wang, Weijing Cui, Yanhong Suo and Xia Gao
    Citation: Lipids in Health and Disease 2022 21:38
  4. Authors: Antonietta Stellavato, Anna Virginia Adriana Pirozzi, Francesca de Novellis, Ilaria Scognamiglio, Valentina Vassallo, Andrea Maria Giori, Mario De Rosa and Chiara Schiraldi
    Citation: Lipids in Health and Disease 2022 21:37

    The original article was published in Lipids in Health and Disease 2018 17:24

  5. The association between serum uric acid (SUA) and the components of dyslipidaemia and their dose-response relationships have not been thoroughly explored. This study assessed the relationship between SUA and e...

    Authors: Lian Peng, Leilei Liu, Nana Ma, Fan Yang, Chan Nie, Tingting Yang, Qibing Zeng, Ziyun Wang, Degan Xu, Lu Ma, Yuyan Xu and Feng Hong
    Citation: Lipids in Health and Disease 2022 21:36
  6. Although high serum cholesterol is widely recognized as a major risk factor for heart disease, the health effects of low cholesterol are less clear. Several studies have found a correlation between low cholest...

    Authors: Qun Zhang, Ziping Liu, Qian Wang and Xiaoqian Li
    Citation: Lipids in Health and Disease 2022 21:35
  7. Dyslipidemia is a significant contributor to cardiovascular and cerebrovascular diseases. Research on the relationship between breakfast consumption frequency and dyslipidemia in the working population is lack...

    Authors: Qi-mei Li, Cheng-kai Wu, Peng-cheng Ma, Hao Cui, Rui-ning Li, Chang Hong, Lin Zeng, Sheng-wu Liao, Lu-shan Xiao, Li Liu and Wen-yuan Li
    Citation: Lipids in Health and Disease 2022 21:33
  8. Recent findings show that extracellular vesicle constituents can exert short- and long-range biological effects on neighboring cells in the brain, opening an exciting avenue for investigation in the field of n...

    Authors: Melissa R. Pergande, Christina Kang, Diann George, Pearl A. Sutter, Stephen J. Crocker, Stephanie M. Cologna and Maria I. Givogri
    Citation: Lipids in Health and Disease 2022 21:32
  9. Omega 3 polyunsaturated fatty acids (n-3 PUFA) are known to have beneficial effects on cardiovascular and metabolic health. However, whether different sources of n-3 PUFA, for instance fatty fish vs vegetable ...

    Authors: Pasquale Mone, Fahimeh Varzideh, Urna Kansakar, Carmine Infante, Angela Lombardi, Antonio de Donato, Salvatore Frullone and Gaetano Santulli
    Citation: Lipids in Health and Disease 2022 21:31
  10. Elevated monocyte-to-high-density lipoprotein-cholesterol ratio (MHR) is relevant to higher all-cause and cardiovascular mortality in patients with coronary artery disease and other comorbidities. However, the...

    Authors: Ming Jiang, Jiaming Yang, Huayiyang Zou, Menghuan Li, Wei Sun and Xiangqing Kong
    Citation: Lipids in Health and Disease 2022 21:30
  11. Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. The fat mass and obesity–associated protein (FTO) has been shown to be involved in obesity; however, its role in NAF...

    Authors: Xiaohui Wei, Jielei Zhang, Min Tang, Xuejiao Wang, Nengguang Fan and Yongde Peng
    Citation: Lipids in Health and Disease 2022 21:29
  12. Conflicting results on the prognostic value of the visceral adiposity index (VAI) in patients with metabolic-associated fatty liver disease (MAFLD) have been reported. This study aimed to assess the diagnostic...

    Authors: Xianhao Yi, Shaihong Zhu and Liyong Zhu
    Citation: Lipids in Health and Disease 2022 21:28
  13. Chemerin is a brand-new adipokine that has been linked to both inflammation and metabolic dysfunction. Even though a rising number of studies have connected chemerin to metabolic-associated fatty liver disease...

    Authors: Qian Ren, Hongya Wang, Yan Zeng, Xia Fang, Mei Wang, Dongze Li, Wei Huang and Yong Xu
    Citation: Lipids in Health and Disease 2022 21:27
  14. Gallstone disease (GSD) is a common and costly biliary disorder. Multiple studies have investigated the associations between blood lipid metabolism and GSD risk; however, the results are inconsistent. This res...

    Authors: Min Zhang, Min Mao, Chi Zhang, Fulan Hu, Ping Cui, Guangcan Li, Jia Shi, Xin Wang and Xuefeng Shan
    Citation: Lipids in Health and Disease 2022 21:26
  15. The relationship of consumption of dietary fat and fatty acids with esophageal squamous cell carcinoma (ESCC) risk remains unclear. This study aimed to explore the relationship of dietary fat and fatty acids i...

    Authors: Yu-Xuan Tang, Wenjing Zhao, Jun Li, Peng Xie, Shuyi Wang, Lubin Yan, Xiangbing Xing, Jiahai Lu, Lap-Ah Tse, Harry Hao-Xiang Wang and Xudong Liu
    Citation: Lipids in Health and Disease 2022 21:25
  16. Obesity and diabetes are two chronic metabolic diseases whose prevalence is increasing at an alarming rate globally. A close association between obesity, diabetes, and insulin resistance has been identified, a...

    Authors: Shahanas Chathoth, Mona H. Ismail, Hanan M. Alghamdi, Hazem Mohamed Zakaria, Khairi Ahmed Hassan, Saeed Alshomimi, Chittibabu Vatte, Cyril Cyrus, Hind S. Alsaif, Ahmed Mostafa, Heba Shaaban and Amein Al Ali
    Citation: Lipids in Health and Disease 2022 21:24
  17. Relatively little is known about the physiological whole blood fatty acid composition in young people. Likewise, few studies have addressed the question of correlations between Mediterranean diet (MedDiet) adh...

    Authors: Marie-Louise Syrén, Stefano Turolo, Erika Adalgisa de Marco, Valentina De Cosmi, Patrizia Risé, Franca Marangoni, Dario Guido Minoli, Gianantonio Manzoni and Carlo Agostoni
    Citation: Lipids in Health and Disease 2022 21:23
  18. Colorectal cancer (CRC) is one of the most common cancers worldwide characterized by disparities in age, gender, race and anatomic sites. The mechanism underlying pathogenesis, progression and disparities of C...

    Authors: Zhirong Liu, Christian R. Gomez, Ingrid Espinoza, Thuy Phuong T. Le, Veena Shenoy and Xinchun Zhou
    Citation: Lipids in Health and Disease 2022 21:22
  19. The prevalence of hypertriglyceridemia has been increasing worldwide. Attention is drawn to the fact that the frequency of a special hypertriglyceridemia entity, named chylomicronemia syndrome, is variable amo...

    Authors: György Paragh, Ákos Németh, Mariann Harangi, Maciej Banach and Péter Fülöp
    Citation: Lipids in Health and Disease 2022 21:21
  20. Dietary fatty acids intake affects the composition of erythrocyte fatty acids, which is strongly correlated with glycolipid metabolism disorders. This study aimed at investigating the different effects of mari...

    Authors: Hechun Liu, Feng Wang, Xiaosong Liu, Yulan Xie, Hui Xia, Shaokang Wang and Guiju Sun
    Citation: Lipids in Health and Disease 2022 21:20
  21. Current guidelines for dyslipidemia management recommend that the LDL-C goal be lower than 70 mg/dL. The present study investigated the prognostic significance of visit-to-visit variability in LDL-C, and minim...

    Authors: Chang-Sheng Sheng, Ya Miao, Lili Ding, Yi Cheng, Dan Wang, Yulin Yang and Jingyan Tian
    Citation: Lipids in Health and Disease 2022 21:19
  22. High-density lipoprotein (HDL) plays a critical role in protection against atherosclerosic and cardiovascular disease (ASCVD). In addition to contributing to clearing excess vascular cholesterol, HDL particles...

    Authors: Shelby M. Flaherty, Elizabeth K. Wood, Carol D. Ryff, Gayle D. Love, Theodoros Kelesidis, Loni Berkowitz, Guadalupe Echeverría, Katherine Rivera, Attilio Rigotti and Christopher L. Coe
    Citation: Lipids in Health and Disease 2022 21:18
  23. Biochemical markers are crucial for determining risk in coronary artery disease (CAD) patients; however, the relationship between fasting blood glucose to high-density lipoprotein cholesterol (FG/HDL-C) ratio ...

    Authors: Simin Deng, Zhaojun Wang, Yifeng Zhang, Ying Xin, Cheng Zeng and Xinqun Hu
    Citation: Lipids in Health and Disease 2022 21:17
  24. Accumulating evidence suggests sleep duration may be involved in metabolic regulation. However, studies regarding the association with the early stage of the metabolic disease are limited, and the findings wer...

    Authors: Lili Huang, Zichong Long, Gang Xu, Yiting Chen, Rong Li, Yanlin Wang and Shenghui Li
    Citation: Lipids in Health and Disease 2022 21:16
  25. Bile acids (BAs) not only play an important role in lipid metabolism and atherosclerosis but also have antiapoptotic and neuroprotective effects. However, few studies have focused on the relationship of the to...

    Authors: Lingling Huang, Ge Xu, Rong Zhang, Yadong Wang, Jiahui Ji, Fengdan Long and Yaming Sun
    Citation: Lipids in Health and Disease 2022 21:15
  26. Calcific aortic valve disease (CAVD) has a substantial and increasing burden in the ageing population with occult onset.Present study aimed to assess association of clinical characteristics of these patients a...

    Authors: Cong Liu, Haifeng Liu and Ting Xie
    Citation: Lipids in Health and Disease 2022 21:14
  27. Benzo [a] pyrene (BaP), a potent carcinogen, has been proved that it has toxicological effects via activation the aryl hydrocarbon receptor (AhR) pathway. AhR can participate in regulating lipogenesis and lipo...

    Authors: Wei Lou, Meng-di Zhang, Qi Chen, Tu-Ya Bai, Yu-Xia Hu, Feng Gao, Jun Li, Xiao-Li Lv, Qian Zhang and Fu-Hou Chang
    Citation: Lipids in Health and Disease 2022 21:13
  28. Diabetic retinopathy (DR) is the primary oculopathy causing blindness in diabetic patients. Currently, there is increasing interest in the role of lipids in the development of diabetic retinopathy, but it rema...

    Authors: Yongyan Shan, Qian Wang, Yitong Zhang, Xuewei Tong, Shengdan Pu, Yuxin Xu and Xinyuan Gao
    Citation: Lipids in Health and Disease 2022 21:12
  29. Sitosterolemia is a lipid disorder characterized by the accumulation of phytosterols in plasma and organs, caused by mutations in the ABCG5 and/or ABCG8 genes. The disease is frequently misdiagnosed and mistreate...

    Authors: Zhizi Zhou, Xueying Su, Yanna Cai, Tzer Hwu Ting, Wen Zhang, Yunting Lin, Aijing Xu, Xiaojian Mao, Chunhua Zeng, Li Liu and Xiuzhen Li
    Citation: Lipids in Health and Disease 2022 21:11
  30. Lipocalin-2 (LCN2) has a critical effect on obesity as well as its associated comorbidities. The present study focused on analyzing serum LCN2 levels of obese patients with nonalcoholic fatty liver disease (NA...

    Authors: Jiaqi Chen, Shihui Lei, Yueye Huang, Xiaojuan Zha, Lei Gu, Donglei Zhou, Jun Li, Feng Liu, Nannan Li, Lei Du, Xiu Huang, Ziwei Lin, Le Bu and Shen Qu
    Citation: Lipids in Health and Disease 2022 21:10
  31. The discovery of the endocannabinoidome (eCBome) is evolving gradually with yet to be elucidated functional lipid mediators and receptors. The diet modulates these bioactive lipids and the gut microbiome, both...

    Authors: Jyoti Sihag and Vincenzo Di Marzo
    Citation: Lipids in Health and Disease 2022 21:9
  32. Lipid accumulation product (LAP) and cardiometabolic index (CMI) are two novel obesity-related indexes associated with enhancing metabolic disease (MD) risk. Current evidences suggest that the differences in s...

    Authors: Yiting Liu and Wei Wang
    Citation: Lipids in Health and Disease 2022 21:8
  33. A novel classification has been introduced to promote precision medicine in diabetes. The current study aimed to investigate the relationship between leptin and resistin levels with novel refined subgroups in ...

    Authors: Xuemin Peng, Jiaojiao Huang, Huajie Zou, Bei Peng, Sanshan Xia, Kun Dong, Nan Sun, Jing Tao and Yan Yang
    Citation: Lipids in Health and Disease 2022 21:7
  34. Phosphatidylinositol 4-phosphate 5-kinase type I c (PIP5K1c) catalyses the synthesis of phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) by phosphorylating phosphatidylinositol 4 phosphate, which play...

    Authors: Guan Huang, Cuishan Yang, Sheng Guo, Miaoling Huang, Liping Deng, Ying Huang, Puxin Chen, Feng Chen and Xiaohong Huang
    Citation: Lipids in Health and Disease 2022 21:6
  35. Recent advances in society have resulted in the emergence of both hyperlipidemia and obesity as life-threatening conditions in people with implications for various types of diseases, such as cardiovascular dis...

    Authors: Bo Wang, Heng Wang, Yuancheng Li and Lei Song
    Citation: Lipids in Health and Disease 2022 21:5
  36. Small, dense low-density lipoprotein (sd-LDL) increases in type 2 diabetes patients and causes arteriosclerosis. Non–high-density-lipoprotein cholesterol (non–HDL-C) is thought to be useful for predicting arte...

    Authors: Gen Ouchi, Ichiro Komiya, Shinichiro Taira, Tamio Wakugami and Yusuke Ohya
    Citation: Lipids in Health and Disease 2022 21:4
  37. The risk of liver fibrosis in non-alcoholic fatty liver disease (NAFLD) can be easily evaluated by noninvasive scoring systems, of which the NAFLD fibrosis score (NFS) is the most commonly used. Proprotein con...

    Authors: Jia Peng, Ming-Ming Liu, Jing-Lu Jin, Ye-Xuan Cao, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, Qian Dong, Jing Sun, Rui-Xia Xu and Jian-Jun Li
    Citation: Lipids in Health and Disease 2022 21:3
  38. Authors: Noriko Suzuki-Kemuriyama, Akari Abe, Kinuko Uno, Shuji Ogawa, Atsushi Watanabe, Ryuhei Sano, Megumi Yuki, Katsuhiro Miyajima and Dai Nakae
    Citation: Lipids in Health and Disease 2022 21:2

    The original article was published in Lipids in Health and Disease 2020 19:251

  39. High levels of apolipoprotein C3 (APOC3) can lead to hypertriglyceridemia, which increases the risk of cardiovascular disease. We aim to create APOC3-knockout (KO) rabbits and explore the effects of APOC3 dele...

    Authors: Yiwen Zha, Yaoyao Lu, Ting Zhang, Kunning Yan, Wenwen Zhuang, Jingyan Liang, Yong Cheng and Yingge Wang
    Citation: Lipids in Health and Disease 2021 20:180
  40. Lipids have a wide variety and vital functions. Lipids play roles in energy metabolism, intracellular and extracellular signal traffic, and transport of fat-soluble vitamins. Also, they form the structure of t...

    Authors: Erkan Cure and Medine Cumhur Cure
    Citation: Lipids in Health and Disease 2021 20:179
  41. Cordyceps militaris is cultured widely as an edible mushroom and accumulating evidence in mice have demonstrated that the polysaccharides of Cordyceps species have lipid-lowering effects. However, lipid metabolis...

    Authors: Wen-Qian Yu, Fan Yin, Nuo Shen, Ping Lin, Bin Xia, Yan-Jie Li and Shou-Dong Guo
    Citation: Lipids in Health and Disease 2021 20:178
  42. Hypertriglyceridemia can occur in lymphoproliferative disorders. Infectious mononucleosis is a self-limiting, benign lymphoproliferative disorder. This study aimed to investigate the serum triglyceride concent...

    Authors: Emilio-Manuel Páez-Guillán, Joaquín Campos-Franco, Rosario Alende, Yago Garitaonaindía and Arturo González-Quintela
    Citation: Lipids in Health and Disease 2021 20:177
  43. To date, there have no study comparing the associations between TyG index and HOMA-IR on the risk of incident albuminuria. Accordingly, the objective of the present study is to use discordance analysis to eval...

    Authors: Wei Gao, Jialu Wang, Yan Chen, Hongmei Qiao, Xiaozhong Qian, Zhuojun Xin, Zhiyun Zhao, Tiange Wang, Yu Xu, Min Xu, Yufang Bi, Mian Li and Jinli Gao
    Citation: Lipids in Health and Disease 2021 20:176
  44. Obstructive sleep apnea (OSA) is a disorder with a significant risk for cardiovascular diseases. Dyslipidemia and redox imbalance belong to potential mechanisms linking OSA with the development of vascular dis...

    Authors: Branislav Kollar, Pavel Siarnik, Alzbeta Hluchanova, Katarina Klobucnikova, Imrich Mucska, Peter Turcani, Zuzana Paduchova, Barbora Katrencikova, Maria Janubova, Katarina Konarikova, Lubica Argalasova, Stanislav Oravec and Ingrid Zitnanova
    Citation: Lipids in Health and Disease 2021 20:175
  45. Familial partial lipodystrophy (FPLD) is a rare disease characterized by selective loss of peripheral subcutaneous fat, associated with dyslipidemia and diabetes mellitus. Reductions in circulating levels of A...

    Authors: Maria C. Foss-Freitas, Baris Akinci, Adam Neidert, Victoria J. Bartlett, Eunju Hurh, Ewa Karwatowska-Prokopczuk and Elif A. Oral
    Citation: Lipids in Health and Disease 2021 20:174
  46. AdipoR1 and AdipoR2 (AdipoRs) are plasma membrane proteins often considered to act as adiponectin receptors with a ceramidase activity. Additionally, the AdipoRs and their yeast and C. elegans orthologs are emerg...

    Authors: Mario Ruiz, Marcus Henricsson, Jan Borén and Marc Pilon
    Citation: Lipids in Health and Disease 2021 20:173
  47. Authors: Afaf El-Ansary, Manan Alhakbany, Abeer Aldbass, Hanan Qasem, Sarah Al-Mazidi, Ramesa Shafi Bhat and Laila Al-Ayadhi
    Citation: Lipids in Health and Disease 2021 20:172

    The original article was published in Lipids in Health and Disease 2021 20:155

Annual Journal Metrics